Bioxytran OTC Stock Forecast - Simple Exponential Smoothing
| BIXT Stock | USD 0.06 0.0004 0.73% |
Bioxytran OTC Stock outlook is based on your current time horizon.
At this time, the value of RSI of Bioxytran's share price is approaching 43 suggesting that the otc stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Bioxytran, making its price go up or down. Momentum 43
Sell Extended
Oversold | Overbought |
Using Bioxytran hype-based prediction, you can estimate the value of Bioxytran from the perspective of Bioxytran response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Bioxytran on the next trading day is expected to be 0.06 with a mean absolute deviation of 0 and the sum of the absolute errors of 0.22. Bioxytran after-hype prediction price | USD 0.06 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bioxytran |
Bioxytran Additional Predictive Modules
Most predictive techniques to examine Bioxytran price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bioxytran using various technical indicators. When you analyze Bioxytran charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Bioxytran Simple Exponential Smoothing Price Forecast For the 27th of January
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Bioxytran on the next trading day is expected to be 0.06 with a mean absolute deviation of 0, mean absolute percentage error of 0.000026, and the sum of the absolute errors of 0.22.Please note that although there have been many attempts to predict Bioxytran OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Bioxytran's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Bioxytran OTC Stock Forecast Pattern
| Backtest Bioxytran | Bioxytran Price Prediction | Buy or Sell Advice |
Bioxytran Forecasted Value
In the context of forecasting Bioxytran's OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Bioxytran's downside and upside margins for the forecasting period are 0.0006 and 7.25, respectively. We have considered Bioxytran's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Bioxytran otc stock data series using in forecasting. Note that when a statistical model is used to represent Bioxytran otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 105.7307 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0036 |
| MAPE | Mean absolute percentage error | 0.0504 |
| SAE | Sum of the absolute errors | 0.219 |
Predictive Modules for Bioxytran
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bioxytran. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bioxytran's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bioxytran After-Hype Price Density Analysis
As far as predicting the price of Bioxytran at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bioxytran or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Bioxytran, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bioxytran Estimiated After-Hype Price Volatility
In the context of predicting Bioxytran's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bioxytran's historical news coverage. Bioxytran's after-hype downside and upside margins for the prediction period are 0.00 and 7.49, respectively. We have considered Bioxytran's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bioxytran is out of control at this time. Analysis and calculation of next after-hype price of Bioxytran is based on 3 months time horizon.
Bioxytran OTC Stock Price Outlook Analysis
Have you ever been surprised when a price of a OTC Stock such as Bioxytran is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bioxytran backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bioxytran, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.26 | 7.19 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.06 | 0.06 | 8.30 |
|
Bioxytran Hype Timeline
Bioxytran is currently traded for 0.06. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Bioxytran is anticipated to increase in value after the next headline, with the price projected to jump to 0.06 or above. The average volatility of media hype impact on the company the price is insignificant. The price appreciation on the next news is projected to be 8.3%, whereas the daily expected return is currently at 0.26%. The volatility of related hype on Bioxytran is about 1.198333333E7%, with the expected price after the next announcement by competition of 0.06. The company has return on total asset (ROA) of (7.0399) % which means that it has lost $7.0399 on every $100 spent on assets. This is way below average. Bioxytran's management efficiency ratios could be used to measure how well Bioxytran manages its routine affairs as well as how well it operates its assets and liabilities. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Bioxytran to cross-verify your projections.Bioxytran Related Hype Analysis
Having access to credible news sources related to Bioxytran's direct competition is more important than ever and may enhance your ability to predict Bioxytran's future price movements. Getting to know how Bioxytran's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bioxytran may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GLWLF | Glow Lifetech Corp | 0.00 | 0 per month | 2.04 | 0.03 | 5.25 | (2.70) | 27.60 | |
| BZYR | Burzynski Research | 0.00 | 0 per month | 11.83 | 0.06 | 29.41 | (23.81) | 113.87 | |
| THER | Therasense | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KNBIF | Kane Biotech | 0.00 | 0 per month | 4.01 | 0.03 | 8.20 | (5.30) | 27.72 | |
| BVAXF | Biovaxys Technology Corp | 0.00 | 0 per month | 6.90 | 0.04 | 13.33 | (10.53) | 43.75 | |
| CPMV | Mosaic Immunoengineering | 0.00 | 0 per month | 12.11 | 0.06 | 51.52 | (22.45) | 106.28 | |
| BETRF | BetterLife Pharma | (0.0006) | 3 per month | 8.54 | 0.01 | 22.58 | (16.33) | 52.18 | |
| TXTM | Protext Mobility | 0.00 | 0 per month | 5.02 | 0.13 | 16.13 | (8.33) | 32.26 | |
| NSHSF | Nanosphere Health Sciences | 0.00 | 0 per month | 0.00 | 0.11 | 0.00 | 0.00 | 216.93 | |
| MYNDF | MYND Lifesciencs | 0.00 | 0 per month | 0.00 | (0.02) | 0.00 | 0.00 | 113.60 |
Other Forecasting Options for Bioxytran
For every potential investor in Bioxytran, whether a beginner or expert, Bioxytran's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bioxytran OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bioxytran. Basic forecasting techniques help filter out the noise by identifying Bioxytran's price trends.Bioxytran Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bioxytran otc stock to make a market-neutral strategy. Peer analysis of Bioxytran could also be used in its relative valuation, which is a method of valuing Bioxytran by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bioxytran Market Strength Events
Market strength indicators help investors to evaluate how Bioxytran otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bioxytran shares will generate the highest return on investment. By undertsting and applying Bioxytran otc stock market strength indicators, traders can identify Bioxytran entry and exit signals to maximize returns.
| Accumulation Distribution | 0.11 | |||
| Daily Balance Of Power | 0.0615 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 0.0535 | |||
| Day Typical Price | 0.0541 | |||
| Market Facilitation Index | 0.0065 | |||
| Price Action Indicator | 0.0022 | |||
| Period Momentum Indicator | 4.0E-4 | |||
| Relative Strength Index | 43.69 |
Bioxytran Risk Indicators
The analysis of Bioxytran's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bioxytran's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bioxytran otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.4 | |||
| Standard Deviation | 7.58 | |||
| Variance | 57.43 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Bioxytran
The number of cover stories for Bioxytran depends on current market conditions and Bioxytran's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bioxytran is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bioxytran's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Additional Tools for Bioxytran OTC Stock Analysis
When running Bioxytran's price analysis, check to measure Bioxytran's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioxytran is operating at the current time. Most of Bioxytran's value examination focuses on studying past and present price action to predict the probability of Bioxytran's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioxytran's price. Additionally, you may evaluate how the addition of Bioxytran to your portfolios can decrease your overall portfolio volatility.